Naşide Gözde Durmuş

from Wikipedia, the free encyclopedia

Naşide Gözde Durmuş (adapted to the German pronunciation: Naschide Gösde Durmusch, * 1985 in Izmir ) is a Turkish geneticist .

She works in the field of nanotechnology and microtechnology to combat current health threats such as cancer or resistance to antibiotics. The MIT Technology Review listed her as one of 35 young leading scientists under the category of pioneers in the magazine "Innovators under 35" (Eng. "35 Innovative under 35").

Life

Durmuş was born in 1985 in Izmir. She did her bachelor's degree with a specialization in molecular biology at the Technical University of the Middle East in Ankara. She later received a Fulbright Scholarship and then moved to the United States for further training. In 2009 she received her Masters of Engineering degree from Boston University . The Ph.D. in Biomedical Engineering from Brown University in May 2013.

In 2014 she accepted a position as a post-doctoral student at Stanford University. She continues to do research in collaboration with Ronald W. Davis at Stanford University in the Genome Engineering Center.

Research topic

Her work focuses on low-cost (affordable) nanotechnology tools that can be used for the diagnosis and treatment of diseases. For example, she analyzes the physical properties of a cell in a magnetic field. In this way, one is able to measure the effects of a drug on a microorganism in a shorter time. With this method one is able to differentiate cancer cells from healthy cells.

Individual evidence

  1. Gozde Durmus | Innovators Under 35 . In: MIT Technology Review . ( technologyreview.com [accessed June 3, 2017]).
  2. Kanser teşhisinde çığır açan buluş. Retrieved June 3, 2017 (Turkish).
  3. https://profiles.stanford.edu/naside-gozde-durmus. Retrieved June 3, 2017 .
  4. Stanford team Develops technique to magnetically levitate single cells . ( phys.org [accessed June 3, 2017]).